1985
DOI: 10.1111/j.2042-7158.1985.tb03061.x
|View full text |Cite
|
Sign up to set email alerts
|

Improvement in the percutaneous absorption of beclomethasone dipropionate by γ-cyclodextrin complexation

Abstract: Inclusion complex formation of beclomethasone dipropionate (BMDP) with gamma-cyclodextrin (gamma-CyD) in water and in solid state was assessed by solubility analysis and X-ray diffractometry. The solid complex of BMDP with gamma-CyD in a molar ratio of 1:2 was prepared and its in-vitro release behaviour was investigated using an ointment release simulator. The release of BMDP from hydrophilic ointment was significantly improved by the gamma-CyD complexation. Permeation and uptake studies indicated that the enh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

1990
1990
2013
2013

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(10 citation statements)
references
References 13 publications
1
9
0
Order By: Relevance
“…It is evident that the release of BP AA was markedly enhanced by the complexations with /1-CyDs. This may be attributed to the faster dissolution and the lower binding affinity of the complexes in the ointment base, as previously described (Uekama et al 1985). The relative potency of /1-CyDs in enhancing the release of BPAA from the ointment base was in the order of /1-< DM-/1-HP-/1-CyD, which is not simply dependent on the magnitude of the stability constants of the complexes: /1-CyDs may exert the enhancing effect in a different manner (Arima et al 1989).…”
Section: Discussionsupporting
confidence: 53%
“…It is evident that the release of BP AA was markedly enhanced by the complexations with /1-CyDs. This may be attributed to the faster dissolution and the lower binding affinity of the complexes in the ointment base, as previously described (Uekama et al 1985). The relative potency of /1-CyDs in enhancing the release of BPAA from the ointment base was in the order of /1-< DM-/1-HP-/1-CyD, which is not simply dependent on the magnitude of the stability constants of the complexes: /1-CyDs may exert the enhancing effect in a different manner (Arima et al 1989).…”
Section: Discussionsupporting
confidence: 53%
“…Binding forces involved in inclusion complexation are hydrophobic interactions, hydrogen bonding, van der Waals forces, the relief of high-energy water from the CD cavity and the relief of conformational strain upon guest inclusion (2)(3)(4). The resulting complexes generally lead to an improvement in some of the characteristics of the guest molecules, eg dissolution rate, bioavailability, membrane permeability and stability (5)(6). The alleviation of local or systemic side effects in the presence of CDs has been described.…”
Section: Nabumetonementioning
confidence: 96%
“…Moreover, the drug in the CyD complex may be displaced by some components of the treatment, depending on the stability constant of the complex. 93,94 CyDs also interact with some components of skin. For example, DM-β -CyD markedly extracts cholesterol from rabbit skin in vitro ( Figure 40.8 ), a process which may reduce the function of skin as a barrier and may eventually contribute in part to the enhancement of drug absorption.…”
Section: Transdermal Absorptionmentioning
confidence: 99%